Free tool
FAERS Monitor: Myfortic
Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations
Reports naming NDA 050791 or its brand name (Myfortic, Mycophenolate Sodium). Reports on generic versions are filed under their own applications.
Reports
32,732
Serious
28,618
87% of reports
Hospitalization
14,168
Death reported
4,507
Any cause; not necessarily from the drug
Most reported reactions
MedDRA preferred terms.
- off label use2,957
- diarrhoea2,043
- drug ineffective1,894
- death1,451
- pyrexia1,363
- acute kidney injury1,344
- nausea1,239
- fatigue1,076
- covid-191,057
- vomiting1,001
- pneumonia997
- headache990
- product use in unapproved indication972
- dyspnoea966
- drug interaction905
Reports by year received
View as table
| Year | Reports |
|---|---|
| 2004 | 25 |
| 2005 | 39 |
| 2006 | 82 |
| 2007 | 123 |
| 2008 | 216 |
| 2009 | 268 |
| 2010 | 362 |
| 2011 | 615 |
| 2012 | 629 |
| 2013 | 624 |
| 2014 | 822 |
| 2015 | 1,134 |
| 2016 | 1,324 |
| 2017 | 1,539 |
| 2018 | 1,831 |
| 2019 | 2,108 |
| 2020 | 2,641 |
| 2021 | 2,419 |
| 2022 | 2,959 |
| 2023 | 3,068 |
| 2024 | 3,608 |
| 2025 | 3,839 |
| 2026 | 2,456 |
Disproportionality screen
Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,021,427 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.
| Reaction | Reports | PRR | 95% CI lower | Chi-squared |
|---|---|---|---|---|
| acute kidney injurySignal | 1,344 | 5.7 | 5.4 | 5,176 |
| covid-19Signal | 1,057 | 3.9 | 3.7 | 2,271 |
| drug interactionSignal | 905 | 3.7 | 3.5 | 1,768 |
| pyrexiaSignal | 1,363 | 2.5 | 2.4 | 1,284 |
| product use in unapproved indicationSignal | 972 | 2.5 | 2.4 | 902 |
| off label useSignal | 2,957 | 2.2 | 2.1 | 1,948 |
| diarrhoeaSignal | 2,043 | 2.0 | 2.0 | 1,108 |
| pneumonia | 997 | 2.0 | 1.9 | 490 |
| vomiting | 1,001 | 1.4 | 1.3 | 101 |
| dyspnoea | 966 | 1.1 | 1.0 | 8 |
| death | 1,451 | 1.1 | 1.0 | 9 |
| headache | 990 | 1.0 | 1.0 | 0 |
| nausea | 1,239 | 1.0 | 1.0 | 0 |
| drug ineffective | 1,894 | 0.9 | 0.9 | 13 |
| fatigue | 1,076 | 0.9 | 0.8 | 16 |
A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.